SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.33 Cr | ₹0.96 Cr | ₹1.67 Cr | ₹2.27 Cr | - |
What is the latest Contingent Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4.33 Cr |
Mar2023 | ₹0.96 Cr |
Mar2022 | ₹1.67 Cr |
Mar2021 | ₹2.27 Cr |
Mar2020 | - |
How is Contingent Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.33 Cr | 349.22 | |
Mar2023 | ₹0.96 Cr | -42.20 | |
Mar2022 | ₹1.67 Cr | -26.48 | |
Mar2021 | ₹2.27 Cr | 0 | |
Mar2020 | - | - |
Compare Contingent Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹3,584.3 Cr | 4.8% | -4.9% | 20.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,908.0 Cr | 3.9% | 2.1% | 12% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,601.0 Cr | 3.6% | -1.6% | 66.9% | Stock Analytics | |
CIPLA | ₹122,197.0 Cr | 3.5% | 2.7% | 0.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,314.0 Cr | 5.6% | 5% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,020.6 Cr | 7.1% | -1.1% | -6.8% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 4.8% |
-4.9% |
20.3% |
SENSEX | 3.1% |
0.5% |
4.5% |
You may also like the below Video Courses